Literature DB >> 7224914

CSF levels of norepinephrine during alcohol withdrawal.

R J Hawley, L F Major, E A Schulman, C R Lake.   

Abstract

Cerebrospinal fluid norepinephrine (NE) levels were determined by radioenzymatic assay in 21 patients with a variety of neurological diseases and 49 patients in acute alcohol withdrawal. A second determination was made in 19 patients who had recovered from the alcohol withdrawal syndrome. Cerebrospinal fluid NE concentration was higher in the patients during alcohol withdrawal (192.3 plus or minus 22.3 pg/mL) and decreased during recovery to 137.8 plus or minus 15.9 pg/mL. The CSF NE level was higher in both groups than in patients with other neurological disorders. This may help explain the adrenergic signs observed during alcohol withdrawal.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7224914     DOI： 10.1001/archneur.1981.00510050055008

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


  14 in total

Review 1.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

2.  Current approaches to the recognition and treatment of alcohol withdrawal and delirium tremens: "old wine in new bottles" or "new wine in old bottles".

Authors:  Theodore A Stern; Anne F Gross; Thomas W Stern; Shamim H Nejad; Jose R Maldonado
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 3.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 4.  CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety.

Authors:  Kristen E Pleil; Mary Jane Skelly
Journal:  Alcohol       Date:  2018-02-02       Impact factor: 2.405

5.  A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.

Authors:  Tracy L Simpson; Carol A Malte; Bergetta Dietel; Dana Tell; Ian Pocock; Robert Lyons; Dana Varon; Murray Raskind; Andrew J Saxon
Journal:  Alcohol Clin Exp Res       Date:  2015-04-01       Impact factor: 3.455

Review 6.  Noradrenergic targets for the treatment of alcohol use disorder.

Authors:  Carolina L Haass-Koffler; Robert M Swift; Lorenzo Leggio
Journal:  Psychopharmacology (Berl)       Date:  2018-02-20       Impact factor: 4.530

Review 7.  Noradrenergic circuits and signaling in substance use disorders.

Authors:  Anthony M Downs; Zoe A McElligott
Journal:  Neuropharmacology       Date:  2022-02-14       Impact factor: 5.273

Review 8.  Neurologic effects of alcoholism.

Authors:  I Diamond; R O Messing
Journal:  West J Med       Date:  1994-09

9.  Hyperalgesia after a Drinking Episode in Young Adult Binge Drinkers: A Cross-Sectional Study.

Authors:  Dokyoung S You; Hunter A Hahn; Thomas H Welsh; Mary W Meagher
Journal:  Alcohol Alcohol       Date:  2020-10-20       Impact factor: 2.826

Review 10.  Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine.

Authors:  Paul J Fitzgerald
Journal:  Subst Abuse       Date:  2013-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.